Results 21 to 30 of about 25,027 (259)

Hypophosphatemia and treatment outcomes of patients in the department of anesthesiology and resuscitation of a multidisciplinary hospital [PDF]

open access: yesВестник Витебского государственного медицинского университета, 2023
Objectives. To determine the effect of hypophosphatemia on the results of treatment of patients in the intensive care unit (ICU) of a multidisciplinary hospital. Material and methods.
V.A. Dudko   +3 more
doaj   +1 more source

Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety

open access: yesExpert Opinion on Drug Safety, 2021
Introduction: The newest intravenous (IV) iron products show an improved safety profile over predecessors, allowing for the rapid administration of relatively high doses. Ferric derisomaltose (FDI; also known as iron isomaltoside), ferric carboxymaltose (
I. Blumenstein   +5 more
semanticscholar   +1 more source

Severe Hypophosphatemia in a Girl with Systemic Lupus Erythematosus [PDF]

open access: yesChildhood Kidney Diseases, 2017
Systemic lupus erythematosus (SLE) is characterized by various symptoms and multi-organ involvement. Hypophosphatemia has been described in several diseases accompanied with systemic inflammation.
Taek Jin Lim   +2 more
doaj   +1 more source

Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.

open access: yesJournal of the American Medical Association (JAMA), 2020
Importance Intravenous iron enables rapid correction of iron-deficiency anemia, but certain formulations induce fibroblast growth factor 23-mediated hypophosphatemia.
M. Wolf   +10 more
semanticscholar   +1 more source

Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia

open access: yesJournal of Clinical Endocrinology and Metabolism, 2021
Purpose In X-linked hypophosphatemia (XLH), excess fibroblast growth factor-23 causes hypophosphatemia and low calcitriol, leading to musculoskeletal disease with clinical consequences.
A. Linglart   +12 more
semanticscholar   +1 more source

Determination of FGF23 Levels for the Diagnosis of FGF23‐Mediated Hypophosphatemia

open access: yesJournal of Bone and Mineral Research, 2022
Fibroblast growth factor‐23 (FGF23) measurement is a critical tool in the evaluation of patients with disordered phosphate homeostasis. Available laboratory reference ranges for blood FGF23 were developed using samples from normophosphatemic individuals.
Iris R. Hartley   +13 more
semanticscholar   +1 more source

Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk. [PDF]

open access: yesPLoS ONE, 2016
Ferric carboxymaltose (FCM) and iron isomaltoside 1000 (IIM) are increasingly used because they allow correction of severe iron deficiency in a single infusion.
Benedikt Schaefer   +11 more
doaj   +1 more source

Hypophosphatemia on ICU Admission Is Associated with an Increased Length of Stay in the ICU and Time under Mechanical Ventilation

open access: yesJournal of Clinical Medicine, 2022
Hypophosphatemia is frequently observed in the ICU and is associated with several impairments such as respiratory failure or infections. We hypothesized that hypophosphatemia on ICU admission is associated with a prolonged duration of mechanical ...
Hannah Wozniak   +7 more
semanticscholar   +1 more source

Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy

open access: yesCancer immunology research, 2022
The data suggest the metabolic demand of adoptively transferred CAR T cells may drive a hypophosphatemia state that is associated with commonly observed neurological symptoms. This study may provide clinicians with a way to monitor for ICANS development.
J. P. Tang   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy